Percutaneous Cryoablation for Symptomatic Peripheral Congenital Hemangioma

Adham Khalil; Tushar Garg; Clifford R Weiss

doi:10.1016/j.jvir.2022.07.013

Percutaneous Cryoablation for Symptomatic Peripheral Congenital Hemangioma

J Vasc Interv Radiol. 2022 Nov;33(11):1349-1354. doi: 10.1016/j.jvir.2022.07.013. Epub 2022 Jul 16.

Authors

Adham Khalil¹, Tushar Garg², Clifford R Weiss²

Affiliations

¹ Division of Vascular and Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: akhalil6@jhmi.edu.
² Division of Vascular and Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

PMID: 35850453
DOI: 10.1016/j.jvir.2022.07.013

Abstract

Congenital hemangiomas (CHs) are rare, benign vascular tumors that are present at birth. They are divided into 3 major subtypes: rapidly involuting CHs, partially involuting CHs, and noninvoluting CHs (NICHs). There is a paucity of data in the literature regarding NICH and its management. Most symptomatic patients with NICH are managed with surgery. However, endovascular embolization, direct percutaneous sclerotherapy, or laser treatment can be used on a case-by-case basis. In this report, 3 cases with peripheral symptomatic NICH treated with percutaneous cryoablation are presented.

MeSH terms

Cryosurgery*
Embolization, Therapeutic*
Hemangioma* / congenital
Hemangioma* / diagnostic imaging
Hemangioma* / surgery
Humans
Infant, Newborn
Sclerotherapy
Vascular Neoplasms*